A Chemiluminescent Immunoassay for Osteocalcin in Human Serum and a Solution to the “Hook Effect”

Table 6

Distribution of clinical samples.

Populations	Conc. of BGP (ng/mL)	Fracture	Osteoporosis	Autoimmune diseases	Cancer	Diabetes	Cardiovascular disease
Postmenopausal female	<10	7	6	43	34	40	2
	10∼30	21	24	117	65	194	17
	>30	1	3	8	28	13	2
Male	<10	1	2	7	43	66	11
	10∼40	6	2	26	58	141	56
	>40	1	0	1	14	1	8